1. Home
  2. VINP vs CTKB Comparison

VINP vs CTKB Comparison

Compare VINP & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VINP
  • CTKB
  • Stock Information
  • Founded
  • VINP 2009
  • CTKB 1990
  • Country
  • VINP Brazil
  • CTKB United States
  • Employees
  • VINP N/A
  • CTKB N/A
  • Industry
  • VINP Investment Managers
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • VINP Finance
  • CTKB Health Care
  • Exchange
  • VINP Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • VINP 616.8M
  • CTKB 718.8M
  • IPO Year
  • VINP 2021
  • CTKB 2021
  • Fundamental
  • Price
  • VINP $9.92
  • CTKB $2.77
  • Analyst Decision
  • VINP Strong Buy
  • CTKB Hold
  • Analyst Count
  • VINP 2
  • CTKB 3
  • Target Price
  • VINP $13.25
  • CTKB $5.67
  • AVG Volume (30 Days)
  • VINP 53.8K
  • CTKB 723.5K
  • Earning Date
  • VINP 05-12-2025
  • CTKB 05-08-2025
  • Dividend Yield
  • VINP 6.42%
  • CTKB N/A
  • EPS Growth
  • VINP N/A
  • CTKB N/A
  • EPS
  • VINP 0.38
  • CTKB N/A
  • Revenue
  • VINP $126,696,258.00
  • CTKB $197,050,000.00
  • Revenue This Year
  • VINP $65.92
  • CTKB $4.02
  • Revenue Next Year
  • VINP $15.47
  • CTKB $8.47
  • P/E Ratio
  • VINP $26.55
  • CTKB N/A
  • Revenue Growth
  • VINP 57.51
  • CTKB N/A
  • 52 Week Low
  • VINP $8.66
  • CTKB $3.27
  • 52 Week High
  • VINP $11.62
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • VINP 61.94
  • CTKB 27.50
  • Support Level
  • VINP $9.75
  • CTKB $2.82
  • Resistance Level
  • VINP $10.25
  • CTKB $3.89
  • Average True Range (ATR)
  • VINP 0.26
  • CTKB 0.19
  • MACD
  • VINP 0.07
  • CTKB -0.08
  • Stochastic Oscillator
  • VINP 84.88
  • CTKB 2.33

About VINP Vinci Partners Investments Ltd.

Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: